Navigation Links
ImpactRx Expands Psychiatry Research Panel to Include Adolescent Psychiatrists
Date:6/14/2011

MOUNT LAUREL, N.J., June 14, 2011 /PRNewswire/ -- ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior announced today that it has expanded its nationwide network of high-value, iPhone-connected physicians.  ImpactRx now has access to 175 adult psychiatrists as well as to a new panel of 150 adolescent psychiatrists.  This expansion enables ImpactRx to better serve the growing neuroscience category, in particular the important ADD/ADHD market, and to more effectively support the needs of its pharmaceutical and biotech clients.

"As the competition increases for face-to-face promotional time with psychiatrists, so does the need for effective tracking, evaluating and reporting the effect of promotional activities on prescribing behavior," says Richard Altus, President and CEO of ImpactRx.  "Our proprietary network of high-value, iPhone-connected psychiatrists continuously captures feedback in real-time, providing our clients a closer view of the relationship between prescribing decisions and influencing metrics such as promotional activity, sales representative effectiveness and marketplace dynamics.  The ImpactData™ will provide our clients with an analytic and strategic edge as well as a better understanding of the psychiatric marketplace as a whole."

ImpactRx's fourteen physician specialty panels include Primary Care, Oncology, Endocrinology, Pulmonology and Neurology.  The expansion of the psychiatry panels strengthens the comprehensive and customizable brand and marketing research solutions offered by ImpactRx.

About ImpactRx

Founded in 2000 and headquartered in Mount Laurel, N.J., ImpactRx's longitudinal panels of high value, iPhone-connected physicians are the exclusive source of continuously-captured promotion and treatment data. Through its proprietary methodology, the Company annually captures one million details and three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx is a private company with investment financing provided by Symphony Technology Group (www.symphonytg.com) and Merck Capital Ventures.  For more information, visit: www.impactrx.com.

CONTACT:

Lesley Bailey
Senior Director, Product Development/Marketing
ImpactRx, Inc.
856-802-4133
lbailey@impactrx.com


'/>"/>
SOURCE ImpactRx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImpactRx Acquired by Symphony Technology Group
2. ImpactRx Releases 2010 Oncology Promotion Report
3. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
4. ImpactRx Tracks Decline in Zetia and Vytorin Prescribing
5. Niutang Expands U.S. Sales Team Hiring Donald Schwenker as Sales Manager, Food Ingredients
6. Siemens Expands Customer Return on Innovation at SNM 2011
7. Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial
8. AmbiCom Renews and Expands Line of Credit With East West Bank
9. Awarepoint Expands Senior Management Team
10. HYCOR Expands Board of Directors to Support Growth in Key Areas
11. Isis Earns $3 Million Payment as Collaboration With GSK Expands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... PROVIDENCE, N.J. , April 26, 2017 Phoenix ... announce its fifteenth year of fulfilling its mission of transforming ... industry is highly scrutinized, Phoenix,s innovative ... the healthcare community about the latest advances in science and ... Phoenix was founded in 2002 by ...
(Date:4/21/2017)... 21, 2017 Halo Labs announces the launch ... analysis system called the Horizon at PEGS 2017 in ... new system analyzes sub visible particulate matter in biopharmaceutical ... screening as early as candidate selection and pre-formulation. ... contract research organization Elion Labs for system ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced ... test throughout the Northeast U.S. , GlycoMark is the only clinically available ... test provides a clinically proven one- to two-week measure of hyperglycemic excursions, often ...
(Date:4/28/2017)... ... 28, 2017 , ... Children and adolescents who enter the ... children in the general population. That’s because foster care is designed to protect ... While no fault of their own, youth who have experienced trauma often have ...
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and drain ... After Tina Howe joined the team, the Bill Howe brand was born and they ... rates, and giving back to the San Diego community in which they worked, lived ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/27/2017)... ... 27, 2017 , ... Today, Jefferson Health in Philadelphia and ... an agreement to create the Jane and Leonard Korman Respiratory Institute in Philadelphia. ... Korman Family Foundation. The collaboration leverages the strengths of each organization and will ...
Breaking Medicine News(10 mins):